ArticleBMC surgery2026
Clinical application of modified suspension-assisted transumbilical single-incision laparoscopic cholecystectomy in overweight/obese patients.
Article in BMC surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveSingle-incisionlaparoscopic cholecystectomy (SILC) is an extremely popular technique due to its minimal invasiveness and superior cosmetic outcomes. However, identification of the bile duct and management of the limited operative space remain significant challenges in obese patients. This study evaluated a modified suspension-assisted transumbilical SILC technique for overweight/obese individuals.
methodsWe retrospectively analyzed the clinical data of 106 overweight or obese patients with benign gallbladder diseases treated at our hospital between November 2022 and November 2024. We divided the patients into two groups: in the observation group, 44 patients underwent modified suspension-assisted transumbilical SILC, and in the control group, 62 patients underwent conventional three-port laparoscopic cholecystectomy. We measured several comparative parameters, including preoperative BMI, abdominal circumference, and C-reactive protein (CRP) levels. Moreover, we evaluated surgical and recovery outcomes, including operative time (from induction of anesthesia to skin closure), intraoperative blood loss, conversion to additional trocars, postoperative hospital stay, intraoperative and postoperative complications, duration of incisional pain, time to first flatus, cost of hospitalization, and patient satisfaction with cosmetic outcomes.
resultsAll procedures were completed. No significant differences were observed between the observation and control groups in baseline characteristics, including sex, age, BMI, abdominal circumference, and preoperative CRP levels (P > 0.05). No significant differences were observed in operative time, intraoperative blood loss, or the rates of documented postoperative complications (P > 0.05). However, the observation group had a significantly shorter postoperative hospital stay, shorter duration of incisional pain, and earlier time to first flatus than the control group (P < 0.05). Additionally, patients in the observation group reported significantly greater satisfaction with cosmetic outcomes (P < 0.05). Patients in neither group experienced complications such as biliary stricture or incisional hernia during the one-year follow-up.
conclusionWhen the modified suspension-assisted transumbilical SILC technique is mastered, it has significant advantages for overweight/obese patients with benign gallbladder diseases, including minimal trauma, rapid recovery, shorter hospital stays, and more desirable cosmetic results. Its application is quite promising in the clinical setting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.